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Acute bronchitis is a common illness in
Australia. In 1990, it was the fifth most fre-
quently managed problem by general
practitioners,1 and often leads to an antibiotic
prescription.2 This use may still continue3
despite guidelines to the contrary.4 Patient
factors may be responsible for some prescrip-
tions but GPs may use antibiotics ‘just in
case’.5 Is there any justification for antibiotics? 
One systematic review of the treatment of
acute cough concluded that any benefit from
antibiotics was marginal and probably offset by
potential side effects,6 while a more recent
Cochrane review of acute bronchitis concludes
that ‘there may be modest benefits, at least
for some patients’ and suggests that ongoing
research efforts be directed at ‘the identifica-
tion of subsets of patients who are most likely
to benefit from antibiotic treatment’.7
We sought to establish how frequently
GPs in Australia prescribe antibiotics for acute
bronchitis, which antibiotics are used, and
whether there are subgroups of patients who
might benefit from their use.
Methods
The study used 3 sources of data. The
Austral ian Sentinel Practice Research
Network (ASPREN) is a national network of
about 80 GPs sponsored by The Royal
Australian College of General Practitioners
(RACGP).8 Information about specific clinical
conditions is collated weekly. The Bettering
the Evaluation and Care of Health (BEACH)
Program continuously collects data from
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OBJECTIVE 
To quantify how frequently general
practitioners in Australia prescribe
antibiotics for acute bronchitis, which
antibiotics are used, and whether there
are subgroups of patients who might
benefit from their use.
DESIGN AND SETTING
A retrospective descriptive study using 3
sets of data: Australian Sentinel Practice
Research Network, the Bettering the
Evaluation and Care of Health (BEACH)
Program, and the General Practice
Research Network (GPRN). 
RESULTS
Over 50% of all patients with ‘acute
bronchitis’ had either chest or one or
more systemic signs on physical
examination. The rate of antibiotic
prescribing for acute bronchitis was
79.6% of acute bronchitis visits using
BEACH data 2001–2002 and varied
from 68.6 (95% CI: 62.8–74.5%) in 2001
to 78.7 (95% CI: 72.2–85.2%) in 1999
using GPRN data. Penicillins, followed
by macrolides, were the most
commonly prescribed antibiotics. 
DISCUSSION 
Australian GPs frequently prescribe
antibiotics for ‘acute bronchitis’
despite guidelines to the contrary. 
One reason may be that many patients
present with chest or systemic signs. 
RESEARCH
Table 1. Definition of acute bronchitis
used by GPs (ASPREN Network, 2002)
Acute bronchitis: Acute cough of less than
14 days duration and at least 
1 other symptom of a respiratory infection
such as symptoms of URTI, sore throat,
sputum production, dyspnoea, wheeze, chest
pain, for which there is no other explanation.
Exclude patients that have a history of chronic
respiratory illness that requires ongoing
treatment such as COPD, bronchiectasis or
asthma.
Chest signs are focal or generalised such as
crepitations, crackles, coarse breath sounds
or wheeze in nonasthmatics. Exclude patients
with signs of consolidation (pneumonia).
Systemic signs are: temperature >38°,
respiratory rate >20, pulse >100, or being
confined to bed.
Acute bronchitis with chest and systemic signs:
As defined above with 1 or more chest signs
and 1 or more systemic signs. Record once only
per episode.
Acute bronchitis with chest signs:
As defined above with 1 or more chest signs
but no systemic signs. Record once only 
per episode.
Acute bronchitis with systemic signs: 
As defined above with 1 or more systemic
signs but no chest signs. Record once only
per episode.
Acute bronchitis without signs:
As defined above without any chest signs or
systemic signs. Record once only per episode.
Australian general practice from approxi-
mately 1000 randomly selected GPs every
year.9 The General Practice Research
Network (GPRN) is a random sample of about
300 Australian GP users of one electronic
patient record called ‘Medical Director’.
Longitudinal de-identified patient data are
extracted and captured for demographics,
prescribing, reasons for prescribing, reasons
for visit, patient history, pathology and radiol-
ogy requests and clinical measurements (eg.
blood pressure, height, weight).10 We deter-
mined the proportion of patients presenting
to their GP with a standardised definition of
acute bronchitis (Table 1) from ASPREN data,
calculated the number of antibiotic scripts
written by GPs for acute bronchitis from
BEACH data from 2001–2002, and GPRN
data from 1999–2002; determining the type
of antibiotic prescribed from GPRN morbidity
data (2001).
Results
We were able to determine from ASPREN
data the presence of local and systemic signs
in those diagnosed with acute bronchitis
(Table 2). All had cough; nearly 49% had no
signs, 27% chest signs, 13% systemic signs,
and 12% had both signs.
Acute bronchitis/bronchiolitis represented
15.3% (2118) of al l  BEACH problems
managed with antibiotics in 2001–2002 and
1.9% of all problems managed (n=139 973)
or 2659 problems. From this we calculated a
rate of antibiotic prescription for acute bron-
chitis/bronchiolitis of 79.6% (2118/2659).
Similar calculations using GPRN data yielded
rates between 68.6% (95% CI: 62.8–74.5%)
and 78.7% (95% CI: 72.2–85.2%) in different
years (Table 3). GPRN data from 2001 were
used to determine the type of antibiotic pre-
scribed for acute bronchitis: out of 2.24
million prescriptions, 337 132 were for antibi-
otics (15.1%), of which almost 5% were for
acute bronchitis. Penicillins and macrolides
were most often prescribed for these condi-
tions (Table 4). 
Discussion
This study has a number of limitations. The
data from each of the sources may not have
been representative of Australian general
practice. Both BEACH and the GPRN ran-
domly selected GPs, but ASPREN did not.
We did not validate any clinical findings or
diagnoses, although ASPREN GPs had
precise diagnostic criteria. Results could par-
ticularly be biased toward overestimating
antibiotic use if GPs included acute exacerba-
tions of chronic obstructive pulmonary
disease (COPD). However, it is evident from
the age range of patients with chest/sys-
temic signs that acute bronchitis was no
more common in the 45 years or more age
group (those at risk of COPD) than in younger
patients. Finally, our results for the percent-
age of consultations for acute bronchitis
(3.5%) is consistent with the Australian GP
Morbidity Survey in 1990 (3.9%).1
The results on diagnosis relied on the
validity and reliability of chest signs. The iden-
tification of wheezes and crackles in patients
with pneumonia is fairly reliable.11 Previous
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Table 4. Type of antibiotic prescribed (recorded by GPRN GPs, 2001)
n (%)
Bronchitis Chest infection Cough LRTI
Penicillin 4591 (39) 1742 (39) 262 (28) 1892 (43)
Macrolide 3852 (33) 1495 (34) 426 (45) 1478 (34)
Cephalosporin 1822 (16) 818 (19) 136 (14) 685 (16)
Tetracycline 1277 (11) 257 (6) 112 (12) 250 (6)
Sulphonamide or trimethoprim 107 (1) 29 (1) 8 (1) 36 (1)
Quinolone 28 (0) 76 (2) 1 (0) 23 (1)
Total 11 677 100 4417 100 945 100 4364 100
Table 3. Rate of antibiotic prescribing for acute bronchitis (using GPRN
data, 1999-2002*)
Year Number of GPs Number of visits Rate of antibiotic prescribing, % 
for acute bronchitis (95% CI)
1999 179 5291 78.7 (72.2–85.2)
2000 304 17 538 73.3 (66.5–80.1)
2001 310 22 006 68.6 (62.8–74.5)
2002 302 22 719 75.7 (71.8–79.6)
* Only data from GPs enrolled for the full year were included 
Table 2. Percentage of 2002 consultations and patients presenting with
acute bronchitis (using ASPREN data)
Totals Percentage of
consultations (%)
Total number of consultations 297 342 –
Average number of consultations per week 111 –
Number of patients with cough without any signs 4918 1.65
Number of patients with cough and chest signs 2721 0.92
Number of patients with cough and systemic signs 1359 0.46
Number of patients with cough, chest and systemic signs 1272 0.43
Total 10 270 3.45
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community based studies have used similar
definitions to ours and it is clear that GPs are
influenced by their presence.5 We accepted
the terms bronchitis, chest infection, cough
and lower respiratory tract infection (LRTI) as
being equivalent to acute bronchitis in data
from the GPRN because in previous work,
using case vignettes, these were the terms
that GPs used to label a group of symptoms
and signs consistent with acute bronchitis.12
We found that Australian GPs frequently
prescribe antibiotics for acute bronchitis
despite concerns that they are overused,13 the
emergence of bacterial resistance is a real
concern,14 and guidelines do not recommend
their use.4 General practitioners may be keen
not to under treat serious respiratory tract
infections, such as community acquired pneu-
monia,15 and believe that many cases of acute
bronchitis need antibiotics.16 Acute bronchitis
can certainly cause serious illness: a patient’s
cough can persist for an average of 2 weeks,
over 25% have not returned to their usual
daily activities 2 weeks later,17 and 36%
confine themselves to bed for days.18 Perhaps
this is why patients also believe they need
antibiotics,19 with these expectations affecting
the prescribing behaviour of GPs for upper20
and lower acute respiratory infections.21
The choice of a penicillin by GPs – with a
macrodide a close second – is similar to that
reported in the United Kingdom.5 A recent
study of LRTI suggests a mixed viral, bacterial
and atypical picture22 with M. pneumonia, B.
pertussis and C. pneumonia often isolated (M.
pneumonia, B. pertussis as part of epidemics)
and S. pneumonia, H. influenza and M.
catarrhalis possibly having a role in secondary
bacterial infections.22,23 Amoxycillin is the treat-
ment of choice for community acquired
pneumonia, so it appears that GPs are at least
covering potential organisms and complica-
tions while minimising potential side effects.
It has been speculated that subgroups of
patients may benefit from antibiotics.24 Age
and comorbidity,17 an elevated C reactive
protein,25 smoking,7 combinations of tachycar-
dia above 100/minute, respiratory rate
>24/minute, temperature >38°C and focal
chest signs,22,24 may predict poorer outcomes.
Conversely GP prescribing is influenced by
the presence of coloured sputum,26 which is
neither predictive of bacterial infection nor
antibiotic effectiveness.27
Clearly we need better data. We hypothe-
sise that there may be 2 groups of patients
with acute bronchitis, ‘uncomplicated’ (not
benefiting from antibiotics) and ‘complicated’
(with poorer outcomes and benefiting from
antibiotics). If we could identify subsets of
patients from their symptoms, signs and
investigations, our prescribing would be more
rational and cost effective and GPs could be
more certain whom to treat, and therefore
who not to treat.
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